Peroxisome proliferator activated receptor-active arylene acetic acid derivatives
US7129268B2 · kind B2 · utility
16Cited by
4References
46Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 24, 2003 |
| Grant date | Oct 31, 2006 |
| Priority date | — |
| Expiry date | Jun 20, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C69/712
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel compounds of the general formula (I),wherein Ar, R1, R2, X1, X2, Y1, Y, and Z are as defined in the specification, the use of these compounds as pharmaceutical compositions, pharmaceutical compositions comprising the compounds and methods of treatment employing these compounds and compositions. The present compounds may be useful in the treatment and/or prevention of conditions mediated by Peroxisome Proliferator-Activated Receptors (PPAR), in particular the PPARδ subtype.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.